1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Gores Holdings XI, Inc. consummated its initial public offering on June 24, 2026, selling 35,880,000 units at $10.00 each for gross proceeds of $358,800,000, including full exercise of the underwriter's over-allotment option. The company placed $358,800,000 in a trust account, held for a future business combination, and filed an audited balance sheet as of June 24, 2026.
IPO of 35,880,000 units at $10.00 per unit on June 24, 2026, including 4,680,000 units from the full over-allotment option
Each unit contains one Class A ordinary share and one-fourth of one warrant exercisable at $11.50 per share
Private sale of 225,000 Class A shares to sponsor Gores Sponsor XI LLC for approximately $2,250,000
$358,800,000 placed in a trust account maintained by Equiniti Trust Company, LLC
ArrowMark Financial Corp. (BANX) said its Chief Financial Officer, Patrick Farrell, retired and that Katherine Jones, 41, was appointed CFO effective June 30, 2026. President Dana Staggs also resigned, and the company's press release gives an August 2, 2026 effective date for her departure. The filing reports no financial results, and the changes affect shareholders mainly through the company's leadership and governance.
Katherine Jones, 41, appointed Chief Financial Officer effective June 30, 2026; the 8-K says she is not expected to receive compensation for the role
Patrick Farrell retired as Chief Financial Officer effective June 30, 2026
Dana Staggs resigned as President; the 8-K gives June 30, 2026, while the press release gives August 2, 2026
Chairman and CEO Sanjai Bhonsle said Staggs's duties will be assumed by several investment team members
BlackRock filed a prospectus supplement and a legal opinion covering up to 12,035,866 common shares that could be issued to holders of Subco Class B-2 units upon redemption. The shares relate to the HPS Investment Partners acquisition, with 7,606,927 issuable on existing units and up to 4,428,939 tied to future deferred consideration. Because the filing registers shares that may be issued later, it could add to the number of shares outstanding over time.
Up to 12,035,866 shares of common stock registered for issuance to Class B-2 SubCo Unit holders
7,606,927 shares relate to units issued as closing consideration for the HPS Transaction, which closed July 1, 2025
Up to 4,428,939 shares relate to deferred consideration units that may be issued subject to post-closing conditions and financial milestones
Filing made June 30, 2026 under an existing automatic shelf registration statement (File No. 333-286025)
Subsidiaries of Lumexa Imaging Holdings, Inc. amended their existing credit agreement on June 30, 2026, providing a secured term loan of approximately $823 million and a secured $250 million revolving credit line. The filing describes new restrictive covenants, a leverage test that applies if revolver usage exceeds 40%, and guarantees and collateral pledged by most subsidiaries, which shareholders should weigh as added debt and lender constraints.
Replacement term loan of approximately $823 million matures in December 2032, priced at SOFR plus 2.50% or Prime plus 1.50%.
Revolving credit facility of $250 million matures in December 2030, with pricing at SOFR plus 2.50% or Prime plus 1.50%, subject to reduction on certain leverage ratios.
If revolver exposure exceeds 40% of the facility at quarter-end, the consolidated net leverage ratio must not exceed 7.50 to 1.
Barclays Bank PLC is administrative agent; the loans are guaranteed and secured by substantially all wholly-owned subsidiaries' assets, subject to exceptions.
On June 30, 2026, Valvoline entered into Amendment No. 1 to its Second Amended and Restated Credit Agreement, refinancing all outstanding Term B Loans into new Refinanced Term B Loans with an aggregate principal of $738,150,000. The filing says the principal amount is unchanged after the amendment, and the pricing changed to adjusted term SOFR plus 1.75% or base rate plus 0.75%, with the maturity date unchanged.
Aggregate principal of Refinanced Term B Loans is $738,150,000, unchanged from immediately before the amendment
Term SOFR borrowings priced at adjusted term SOFR plus 1.75%; base rate borrowings at base rate plus 0.75%
Quarterly amortization of 0.25% begins September 30, 2026; maturity remains seven years after December 1, 2025
A 1.00% prepayment premium applies to certain repricing transactions in the six months after June 30, 2026
Alpex Acquisition Corporation, a blank check company, said holders of 11,500,000 units sold in its initial public offering may separately trade the Class A ordinary shares, warrants and rights starting on or about July 7, 2026. Units that are not separated will keep trading under the symbol ALPXU, so shareholders can choose how to hold each component.
Separate trading of Class A ordinary shares, warrants and rights begins July 7, 2026, per the press release
Separated components will trade on Nasdaq as ALPX, ALPXW and ALPXR; unseparated units remain ALPXU
Holders must have their brokers contact transfer agent VStock Transfer LLC to separate units
D. Boral Capital LLC was sole book-running manager; the Form S-1 was declared effective June 24, 2026
Cantor Equity Partners I, Inc. (CEPO) has postponed the extraordinary general meeting where shareholders will vote on its proposed business combination with BSTR Holdings, Inc. to 10:00 a.m. Eastern on July 10, 2026. The deadline for Class A shareholders to submit shares for redemption was extended to 5:00 p.m. Eastern on July 8, 2026, and the proposed resolutions are unchanged. The meeting has now been moved twice, which pushes back the timing of the vote on the deal.
Meeting moved from July 2, 2026 to 10:00 a.m. Eastern on July 10, 2026, after an earlier postponement from June 26, 2026.
Redemption deadline for Class A ordinary shares extended to 5:00 p.m. Eastern on July 8, 2026.
Proposed business combination with BSTR Holdings, Inc.; record date remains June 5, 2026 and proposed resolutions are unchanged.
KORU Medical Systems signed Amendment No. 1 to its manufacturing and supply agreement with Command Medical Products on June 24, 2026, covering subassemblies, needle sets and tubing. The amendment extends the initial term to December 31, 2031, makes Command the exclusive manufacturer of a limited set of products, and requires Command to qualify a second manufacturing site by December 31, 2027, with a termination right for KORU if it does not. The filing discloses no financial figures, so its effect on shareholders' results cannot be measured from this document.
Amendment dated June 24, 2026 modifies the January 1, 2024 agreement with Command Medical Products, LLC.
Initial term now expires December 31, 2031, with automatic one-year renewals unless either party gives at least 180 days' notice.
Command must obtain and qualify a second manufacturing site by December 31, 2027; KORU may terminate if Command fails and does not cure within 30 days.
Amendment also changes pricing and payment terms, establishes Command as exclusive manufacturer of a limited set of products, and removes the non-competition provision.
LTC Properties entered into a Second Amendment to its Credit Agreement on June 26, 2026, increasing aggregate lender commitments from $800 million to $1.1 billion, with revolving commitments rising from $600 million to $900 million. The company also entered into 3-year interest rate swaps to fix the rate on $150 million of borrowings at 4.97% per annum, giving it more borrowing capacity and a set rate on part of its debt.
Aggregate lender commitments increased from $800 million to $1.1 billion on June 26, 2026, via the incremental facility.
Revolving credit commitments rose by $300 million, from $600 million to $900 million.
Maximum permitted total commitments were raised from up to $1.2 billion to up to $2.0 billion.
3-year interest rate swaps fix the rate on $150 million under the Credit Agreement at 4.97% per annum.
REalloys Inc. said Chief Financial Officer Robert Winspear resigned effective June 24, 2026, and the board named Craig Cunningham as his successor the same day, through a consulting agreement with Provenance Advisors Inc. A director, Joseph Sawyer, also resigned effective June 29, 2026, and the board does not plan to fill that seat. The CFO change and the consulting-based pay package are the main items for shareholders to note.
Robert Winspear's CFO separation agreement provides a $200,000 lump-sum severance payment, 20,000 fully vested restricted shares, and a tax-related cash payment.
Craig Cunningham, age 43, was appointed CFO effective June 24, 2026, under a 24-month consulting agreement with Provenance Advisors at $55,000 per month.
Cunningham's initial long-term incentive award has a target grant-date value of $990,000.
Director Joseph Sawyer resigned effective June 29, 2026; the board does not intend to fill the vacancy.
On June 30, 2026, GAMCO Natural Resources, Gold & Income Trust amended its sales agreement to allow it to sell up to 2,000,000 common shares through an at-the-market offering, and it began that offering the same day. Shares may only be sold at or above net asset value per share plus the sales commission, and the offering is made under an existing shelf registration statement.
Up to 2,000,000 common shares may be offered and sold through the Sales Manager, G.research, LLC, and Gabelli Funds, LLC.
Minimum sale price on any day is the then-current net asset value per share plus the per share commission.
The offering was commenced June 30, 2026, under a prospectus supplement dated June 30, 2026 and a prospectus dated February 5, 2024.
The amended sales agreement was originally dated April 22, 2025; Skadden, Arps, Slate, Meagher & Flom LLP provided an opinion on the legality of the shares.
Perrigo Company plc's Board appointed Salman Amin and Omer Gajial as directors effective June 30, 2026, increasing the Board from 8 to 10 members. The filing describes both as independent directors, and it does not report any financial results or changes to guidance.
Salman Amin, age 66, previously served as Chief Executive Officer of pladis Global and joins the Audit Committee and Nominating and Governance Committee.
Omer Gajial, age 52, currently serves as Chief Executive Officer of GoTo Foods and joins the Talent and Compensation Committee.
Both appointments are effective June 30, 2026; the Board size increased from 8 to 10.
Each new director will receive non-employee director compensation as described in the proxy statement filed March 20, 2026.
Patrick Industries agreed to acquire LCI Industries in an all-stock merger in which LCI shareholders receive 1.2440 Patrick shares for each LCI share. After closing, Patrick holders would own about 52% of the combined company and LCI holders about 48%, and the company is expected to close in the first half of 2027, subject to shareholder and regulatory approvals.
Exchange ratio: 1.2440 Patrick common shares for each LCI common share, plus cash in lieu of fractional shares
Ownership after closing: about 52% Patrick shareholders and 48% LCI shareholders
Companies cite more than $150 million of estimated run-rate cost synergies, to be achieved within three years of closing
Outside Date for the Mergers is March 30, 2027, with two three-month extensions possible for regulatory conditions; Andy Nemeth remains CEO and Todd Cleveland is named Chair
Advanced Biomed Inc. agreed on June 30, 2026 to sell 100% of Advanced Biomed Inc. (Taiwan), its wholly-owned subsidiary that runs its biomedical research and development, to an unrelated third party. The filing says the company will keep its remaining businesses, including AI-focused operations through Acellent Technologies (Hong Kong) Co. Limited, and the closing is expected within three months.
Aggregate purchase price is US$490,000, subject to the agreement's terms and conditions.
The Taiwan Subsidiary conducts the company's biomedical R&D, including the A+PerfusC 3D cell culture platform.
Closing is expected within three months of the agreement date; the filing lists closing conditions as a risk factor.
The full Share Purchase Agreement is filed as Exhibit 10.1.
Spire Inc. completed the sale of its Spire Storage businesses, which hold natural gas storage assets in Wyoming and Oklahoma, to an affiliate of I Squared Capital on June 30, 2026. The 8-K gives total consideration of $657 million, while the accompanying press release states $650 million, so the figures differ slightly. Spire says the proceeds will support its regulated utility operations, capital plan and debt reduction, and help fund its earlier Piedmont Natural Gas Tennessee acquisition.
Total consideration is $657 million in the 8-K: $607 million cash at closing, subject to price adjustments, plus $50 million deferred until September 30, 2027.
The press release states $650 million total ($600 million cash at closing plus a $50 million deferred payment in fiscal 2027).
Proceeds help fund the Piedmont Natural Gas Tennessee acquisition, which closed March 31, 2026.
The storage business will operate as Bear River Midstream LLC under I Squared; the Wyoming assets can provide up to 55 Bcf of working gas capacity and the Oklahoma facility up to 17 Bcf.
Seadrill Finance Limited, a wholly owned subsidiary of Seadrill Limited, issued $700 million of 6.750% senior notes due 2034 on June 30, 2026. The company used part of the proceeds to deposit funds that fully cover the redemption of its remaining 8.375% senior secured second lien notes due 2030, discharging that indenture, and it also reported an amended revolving credit facility that increased commitments from $225 million to $300 million, effective June 30, 2026 and undrawn to date.
$700 million of 6.750% senior notes issued June 30, 2026, maturing July 15, 2034
Proceeds deposited to redeem all outstanding 8.375% 2030 notes, of which about $575 million was outstanding as of March 31, 2026
Revolving credit facility commitments increased from $225 million to $300 million, effective June 30, 2026, with no draws to date
Notes callable on or after July 15, 2029 at 103.375% in 2029 and 101.688% in 2030
Vistra Operations, an indirect subsidiary of Vistra Corp., amended its main credit agreement on June 24, 2026, raising aggregate revolving credit commitments from $3.44 billion to $5.50 billion. The amendments also release guarantors from related guarantees, remove collateral reinstatement requirements, and amend or remove certain covenants, and a separate commodity-linked credit agreement was amended to release guarantors. The filing does not state financial results or a reason for the changes, but it expands the company's available revolving borrowing capacity.
Revolving credit commitments increased from $3.44 billion to $5.50 billion under the Credit Agreement Amendment, effective June 24, 2026
Each guarantor released from its guarantee related to revolving loans, commitments, letters of credit and secured cash management agreements
Commodity-Linked Credit Agreement amended to release each guarantor, effective June 24, 2026
Citibank, N.A. serves as Administrative and Collateral Agent under both agreements
On June 25, 2026, Worthington Steel entered into a $550 million asset-based revolving credit agreement with Wells Fargo as agent, replacing its November 2023 facility with PNC Bank. The new facility matures June 25, 2031, and its proceeds are to fund the Klöckner acquisition transactions, working capital and general corporate purposes. The filing states no borrowing amounts, and shareholders would be affected mainly by the facility's size, cost and covenants.
Credit agreement dated June 25, 2026, provides up to $550 million, with an uncommitted increase of up to $200 million and a committed increase to $650 million before the Klöckner increase termination date.
Former facility, dated November 30, 2023, would have matured November 30, 2028; it was terminated on June 25, 2026, with its security interests released.
Facility matures June 25, 2031 and is secured by substantially all assets of the company and its guarantors.
Borrowings bear interest at base rate plus 0.250% or 0.375%, or term SOFR plus 1.250% or 1.375%, depending on excess availability.
Papa John's Chief Financial Officer and President, North America Ravi Thanawala is leaving effective June 30, 2026 to become CFO at another public company, and Chris Collins has been named interim CFO while the company searches for a permanent replacement. The filing states the resignation was not due to any disagreement with the company, and Thanawala will advise through July 31, 2026, with no severance entitlement.
Ravi Thanawala resigns as CFO and President, North America, effective June 30, 2026; advisory role through July 31, 2026
Christopher K. Collins, 56, SVP of Corporate Finance and Principal Accounting Officer, appointed interim CFO effective June 30, 2026
Collins' base salary raised to $415,000 and target bonus set at 75% of base salary while he serves as interim CFO
Marc Richard, SVP of North America Operations, takes over all North America operations; second quarter results due August 6, 2026
Rush Enterprises said its Class A and Class B common stock was approved for dual listing on Nasdaq Texas, with trading expected to start July 1, 2026. The company said the dual listing will not affect where shareholders can trade, involve new shares, or change governance or reporting, and the filing also disclosed new base salaries for four named executive officers effective July 1, 2026.
Trading on Nasdaq Texas expected to begin July 1, 2026, under the symbols RUSHA and RUSHB.
The primary listing remains on the Nasdaq Global Select Market; the dual listing involves no new share issuance.
Chairman, President and CEO W.M. "Rusty" Rush's annual base salary is set at $1,855,802, effective July 1, 2026.
CFO Steven L. Keller's annual base salary is set at $562,506; COO Jody Pollard's at $530,450 and Corey Lowe's at $527,193.
Fox Corporation entered a $1.0 billion senior unsecured term loan credit agreement on June 30, 2026, with Morgan Stanley Senior Funding as administrative agent. The lenders' commitment is contingent on the Roku acquisition closing, and proceeds will pay part of the cash consideration and related amounts, adding debt that shareholders will need to track against the deal's terms.
Facility size: $1.0 billion senior unsecured term loan, with the ability to incur up to $1.0 billion of additional term loans subject to conditions
Funding is contingent on consummation of the Roku, Inc. acquisition, announced June 15, 2026
Loans mature two years after the acquisition closes and funds; the company must maintain an operating income leverage ratio of 4.5 to 1.0
Commitment fees on unused commitments begin accruing October 12, 2026
W. P. Carey Inc. agreed on June 29, 2026 to sell $350 million of 5.200% Senior Notes due 2036 in a public offering, priced at 99.015% of principal. The company plans to use the proceeds mainly to repay its $350 million of 4.250% Senior Notes due October 2026, with the rest for general corporate purposes, including repaying other debt. The offering is expected to settle on July 2, 2026, so the deal refinances existing debt and does not change the principal amount owed.
Offering: $350 million aggregate principal of 5.200% Senior Notes due 2036, priced at 99.015% of principal
Expected settlement date: July 2, 2026, subject to customary closing conditions
Use of proceeds: repay $350 million of 4.250% Senior Notes due October 2026 and for general corporate purposes, including other indebtedness and the $2.0 billion unsecured revolving credit facility
Interest is payable semi-annually on March 15 and September 15, beginning March 15, 2027
HighPeak Energy entered into amendments to two of its credit agreements: a Fourth Amendment to its Fifth Third Bank credit agreement dated June 30, 2026, and a Third Amendment to its Texas Capital Bank term loan dated June 25, 2026. Both amendments set the Total Net Leverage Ratio at not to exceed 2.25 to 1.00 for the quarter ending June 30, 2026, and the company filed the full texts as exhibits.
June 30, 2026: Fourth Amendment to Credit Agreement with Fifth Third Bank, National Association, as administrative agent
June 25, 2026: Third Amendment to term loan credit agreement with Texas Capital Bank as administrative agent and Chambers Energy Management, LP as collateral agent
Both amendments set the Total Net Leverage Ratio at not to exceed 2.25 to 1.00 for the fiscal quarter ending June 30, 2026
Lattice Semiconductor entered a Second Amended and Restated Credit Agreement with Wells Fargo as administrative agent, providing a $200.0 million senior secured revolver and a $950.0 million senior secured delayed draw term loan. No amounts were outstanding at closing, and the term loan may be used to help pay the cash purchase price for the previously announced AMI acquisition. The facility adds debt that is secured by substantially all of the company's and guarantors' assets and must be repaid in quarterly installments after any draw.
Revolving loan of $200.0 million, usable for working capital and general corporate purposes, with commitments and loans due June 30, 2031; no revolving loans outstanding at closing.
Delayed draw term loan of $950.0 million for the AMI acquisition and related fees and expenses; no term loans outstanding at closing, and the commitment ends November 9, 2026 if not used earlier.
Borrowings bear interest at SOFR plus a margin of 1.00% to 1.75%, or a base rate option, with a 0.25% per annum ticking fee on undrawn term loan commitments.
Obligations are secured by substantially all assets and require compliance with total net leverage and interest coverage ratios tested quarterly.
ZW Data Action Technologies said its subsidiary CNET Technology Limited signed a June 26, 2026 agreement to buy an 8.0% equity interest in Margo Asia Limited from Affirm Mission Limited. The purchase price is $474,000 in cash plus 180,000 company common shares valued at $126,000, and closing is subject to customary conditions. The filing is a small acquisition with modest cash and share cost relative to the company's size, as the filing gives no financial data for the company or Margo.
Agreement dated June 26, 2026, between subsidiary CNET Technology Limited, Affirm Mission Limited and Margo Asia Limited
Cash consideration of $474,000 plus 180,000 common shares valued at $126,000, or $0.70 per share
Closing is subject to customary terms and conditions set out in the agreement, included as Exhibit 10.1
ALX Oncology said Chairman Corey Goodman, Ph.D. resigned from the board effective June 29, 2026, for personal reasons and not over any disagreement with the company. The board named independent director Scott Garland as chairman and reset committee memberships, and the company also appointed Michael Listgarten as General Counsel. The filing reports no financial results, so the change is a governance update rather than a change in operating performance.
Corey Goodman, Ph.D. resigned as chairman and as a director, effective close of business June 29, 2026
Scott Garland, an independent director since November 2022, became chairman effective June 29, 2026
Garland joins the Audit Committee; Chris Takimoto, M.D., Ph.D., chairs the Compensation Committee
Michael Listgarten was appointed General Counsel, effective immediately, per the June 30, 2026 press release
MarineMax refinanced its existing credit agreement on June 29, 2026, with a new $1.49 billion package of senior secured facilities maturing in June 2031. The company says the deal lowers borrowing costs, adds revolving capacity and extends its debt maturities by five years, though the filing does not disclose prior interest rates.
Facilities total $1.49 billion: $950 million floor plan, $302.5 million term loan, $150 million revolver (up from $100 million) and $85 million delayed draw mortgage facility, of which $35 million is outstanding
All facilities mature in June 2031; M&T Bank is administrative agent and Wells Fargo Commercial Distribution Finance is floor plan agent
Floor plan borrowings carry a rate of SOFR plus 3.25%; revolver and term loan rates range from SOFR plus 1.50% to 2.0% depending on net leverage
Exicure's board accepted the resignation of director Ham Jung Kyu, expanded the board from five to six seats, and appointed Han Eui Seok and Go Jin Young as Class III directors, all effective June 30, 2026. The filing also creates a Compensation Committee chaired by Mr. Han, which governs pay decisions for the company's leadership and is a governance change shareholders may track.
Ham Jung Kyu resigned from the board effective June 30, 2026, with no disagreement with company operations, policies or practices cited.
Board size increased from five to six directors, effective June 30, 2026.
Han Eui Seok was appointed as an independent director and named chair of the new Compensation Committee; Dongho Lee was named a member.
Go Jin Young was appointed as a non-independent Class III director, based on his anticipated role at the company.
Retractable Technologies' board declared quarterly dividends on its Series II and Series III Class B Convertible Preferred Stock, totaling $39,050.00 and $18,561.25. The dividends cover April 1 through June 30, 2026, and will be paid July 20, 2026 to holders of record on July 10, 2026. The routine payout is a small, scheduled distribution to preferred holders and does not include any change in operating results.
Series II Class B dividend: $39,050.00
Series III Class B dividend: $18,561.25
Dividends accrued at $1.00 per share per annum for April 1 to June 30, 2026
Payment date July 20, 2026; record date July 10, 2026
The trust for the STRATS 2004-6 certificates made its scheduled June 15, 2026 distribution to holders, funded by 6.70% Senior Notes of United States Cellular Corporation. The filing is a routine trustee notice with no principal paid and no interest in arrears, so it carries no clear change in the underlying company's results or outlook.
Class A-1 certificates received $0.318750 per $10 certificate, all interest, with no principal
Class A-2 certificates received $1.625000 per $1,000 notional amount, all interest
Underlying asset is $12,500,000 of 6.70% Senior Notes due December 15, 2033 issued by United States Cellular Corporation
No interest was due and unpaid as of the distribution date
Autoliv said Kevin Fox, President of Autoliv Americas, will resign. He stays in the role through August 31, 2026, then serves as senior advisor to the CEO through February 28, 2027 to support the transition. General Counsel Anthony Nellis will act as president after August 31, 2026, until a successor is appointed, with his base salary raised 30% during that period.
Fox notified the company on June 24, 2026, and the company says the departure is not due to any disagreement.
Fox remains president through August 31, 2026, then serves as executive senior advisor to the CEO through February 28, 2027.
Anthony Nellis, EVP Legal Affairs and General Counsel, will serve as acting President, Autoliv Americas after August 31, 2026.
Nellis's base salary will increase by 30% while he serves as acting president.
PPL Corporation's board elected Kenneth M. Hartwick as a director, effective July 1, 2026. He previously served as president and chief executive officer of Ontario Power Generation from 2019 to 2025, and the filing says his utility CEO and CFO experience will strengthen the board. The filing does not describe any financial effect on PPL, and Hartwick will receive the same non-employee director compensation as other directors.
Board elected Hartwick on June 30, 2026, effective July 1, 2026.
Hartwick was president and CEO of Ontario Power Generation from 2019 to 2025.
He will serve on the People and Compensation Committee and Finance Committee.
With his appointment, the board will have 10 directors.
Kennametal appointed Amanda Cole as Vice President and Chief Human Resources Officer, effective July 21, 2026, succeeding Judith Bacchus, who will retire on or about October 1, 2026. Cole is joining from Wesco International, where she served as a human resources vice president, and her compensation includes a $375,000 base salary and a $300,000 special long-term incentive grant.
Amanda Cole starts as Vice President and Chief Human Resources Officer on July 21, 2026, reporting to CEO Sanjay Chowbey.
Judith Bacchus, who has held the HR role since June 1, 2011, will remain as Vice President and Chief Administrative Officer until she retires on or about October 1, 2026.
Cole receives a $375,000 annual base salary, a $58,000 sign-on bonus, and a $300,000 special RSU grant on August 1, 2026, with a fiscal 2027 target bonus of 50% of base salary.
Easterly Government Properties entered into a new $200 million senior unsecured term loan maturing June 2031, with an accordion feature allowing up to $250 million in total. The company said it will use the proceeds to repay borrowings under its $400 million revolving credit facility and for general corporate purposes. The filing also amends its 2016 term loan to remove the SOFR credit spread adjustment, a change that affects borrowing costs for shareholders only indirectly.
New $200 million senior unsecured term loan dated June 25, 2026, with accordion capacity of up to $50 million for a $250 million total
Loan matures in June 2031; initial spread to SOFR set at 1.30%, within a range of 1.20% to 1.70% based on leverage ratio
Proceeds intended to repay borrowings under the $400 million unsecured revolving credit facility and for general corporate purposes
Eleventh Amendment to the 2016 term loan removes the credit spread adjustment on SOFR-based borrowings
Sharplink disclosed that between June 24 and June 26, 2026, it bought 10,000 ETH for about $16.1 million using proceeds from a $75 million registered direct offering that closed June 23, 2026, and repurchased 2,132,773 shares at an average of $4.69. As of June 28, 2026, its total ETH holdings were 886,725. The filing reports token purchases and share buybacks but no financial results, so shareholders get a snapshot of how the offering capital is being deployed.
Registered direct offering of common stock and warrants raised $75 million and closed June 23, 2026.
Bought 10,000 ETH from June 24 to June 26, 2026, at a weighted average of $1,611.04 per ETH, including fees and expenses.
Total ETH holdings were 886,725 as of June 28, 2026, with substantially all deployed in staking.
Repurchased 2,132,773 shares at an average of $4.69 from June 24 to June 26, 2026; 4,071,223 shares repurchased since the August 2025 program, which authorizes up to $1.5 billion.
Cartesian Growth Corp IV closed its initial public offering on June 26, 2026, selling 27,500,000 units at $10.00 per unit for gross proceeds of $275,000,000. The company placed $275 million in a trust account for public shareholders, and funds there generally stay restricted until a business combination or certain redemptions occur. The company describes itself as a blank check company, and the filing does not identify a target business.
Closed June 26, 2026: 27,500,000 units at $10.00 each, gross proceeds $275,000,000, including 2,500,000 units from the partial over-allotment exercise.
$275 million ($10.00 per unit) placed in a trust account, with Continental Stock Transfer & Trust Company as trustee.
Private placement of 2,500,000 warrants at $2.00 each, for gross proceeds of $5,000,000: 937,500 to the sponsor and 1,562,500 to Cantor.
Yongchen Lu, Monica Roma Wilson and Eduardo Agustin Ojea Quintana were appointed to the board effective June 24, 2026.
LCI Industries and Patrick Industries signed a merger agreement on June 30, 2026 under which LCI would become a wholly owned subsidiary of Patrick, and LCI shareholders would receive 1.2440 Patrick shares for each LCI share. After closing, Patrick holders would own about 52% of the combined company and LCI holders about 48%, and the deal is expected to close in the first half of 2027, subject to shareholder, regulatory and other conditions.
Exchange ratio: 1.2440 shares of Patrick common stock for each LCI common share, plus cash in lieu of fractional shares
Ownership after closing: Patrick shareholders about 52%, LCI shareholders about 48%
The companies estimate more than $150 million of run-rate cost synergies, achieved within three years of closing
Outside Date for completion is March 30, 2027; expected closing is the first half of 2027
Monopar Therapeutics said the U.S. Food and Drug Administration granted Rare Pediatric Disease designation to ALXN1840 (tiomolibdate choline), its late-stage candidate for Wilson disease. The designation gives the company the potential to receive a pediatric Priority Review Voucher if the drug is approved, but the filing does not say whether approval will come or whether a voucher will be awarded.
FDA granted Rare Pediatric Disease designation to ALXN1840 for Wilson disease, announced June 30, 2026
The designation provides potential eligibility for a pediatric Priority Review Voucher at the time of NDA approval
The filing does not report revenue, earnings, or guidance
Pacira agreed on June 28, 2026 to sell its iovera handheld cryoanalgesia device business, including subsidiary Pacira CryoTech, to Zimmer, a subsidiary of Zimmer Biomet, for up to $140 million. The deal includes a $70 million upfront payment and up to $70 million in revenue-based milestone payments through December 31, 2031, and is expected to close in the third quarter of 2026. The company says it intends to use the upfront proceeds to strengthen its balance sheet, including paying down its senior secured revolving credit facility.
Upfront payment of $70.0 million, subject to customary adjustments for cash, receivables, indebtedness, transaction expenses and inventory
Milestone payments of $18.5 million, $23.5 million and $28.0 million if annual iovera net revenue reaches $50 million, $60 million or $70 million in any period from 2027 through 2031
66 employees expected to join Zimmer, about 8% of Pacira's total workforce
Purchase Agreement signed June 28, 2026; transaction expected to close in the third quarter of 2026
Creative Realities agreed to sell 2,528,571 common shares at $3.50 each, plus pre-funded warrants for 900,000 shares, with gross proceeds expected to be about $12.0 million. The company plans to use the net proceeds of about $10.9 million to repay $1 million of its term loan and pay down its revolving loan, which would increase availability for potential acquisitions and general corporate purposes. The new shares add to the number of shares outstanding, and the offering is expected to close on June 30, 2026.
2,528,571 common shares priced at $3.50 each; pre-funded warrants for 900,000 shares priced at $3.49 each.
Expected gross proceeds of about $12.0 million and net proceeds of about $10.9 million, or about $12.3 million if the underwriter's 428,614-share option is exercised in full.
Proceeds to repay $1 million of the term loan and pay down the revolving loan.
Expected closing on June 30, 2026; offering made under a shelf registration declared effective June 16, 2026, with Craig-Hallum Capital Group LLC as underwriter.
Angel Studios amended and restated its merger agreements to acquire Tuttle Twins Show, LLC (TTS) and Toothy Cow Productions, LLC (TCP), both signed November 14, 2025. The changes extend the outside date to October 31, 2026, and alter several closing conditions and the TCP merger structure. Company insiders and affiliates hold units in both companies and would receive Class A shares in the deals, and the company has already provided funding to both.
Outside date for both the TTS and TCP mergers extended to October 31, 2026
Closing condition requiring a showrunner agreement for Daniel Harmon removed from the TTS deal
Company related parties own 41.6% of TTS units and 2.4% of TCP units as of June 23, 2026
Company has provided $11.7 million to TTS and $11.9 million to TCP to date, with a maximum TCP funding commitment of $11.9 million
Rani Therapeutics appointed Nicholas M. Maestas as Chief Financial Officer, succeeding Svai Sanford, who had previously announced he would step down once a successor was named. The company also approved a 2026 Equity Inducement Plan reserving 5,500,000 Class A shares for new-hire awards, which does not require stockholder approval.
Maestas, age 46, was CFO and Head of Corporate Strategy at Tempest Therapeutics from January 2025 until June 2026.
Offer letter dated June 24, 2026 sets an annual base salary of $500,000 and a target bonus of 75% of base salary.
Maestas will receive a non-qualified option to purchase 2,000,000 Class A shares, vesting over four years.
The Board approved the Inducement Plan on June 28, 2026, reserving 5,500,000 shares.
General Fusion and Spring Valley Acquisition Corp. III filed an updated investor presentation under Regulation FD, replacing the version furnished on April 29, 2026. The presentation covers the proposed business combination, which the SEC declared effective on June 12, 2026, and the related proxy materials mailed to Spring Valley shareholders on June 15, 2026.
Updated presentation (Exhibit 99.1) supersedes the version filed with the SEC on April 29, 2026
SEC declared the Form F-4 registration statement effective on June 12, 2026
Proxy statement mailed June 15, 2026 to Spring Valley shareholders of record as of June 12, 2026
Presentation cites a $600 million General Fusion pre-money valuation and a $108 million PIPE priced at $12.00 per share
OceanFirst Financial Corp. completed the sale of $1.3 billion of multifamily loans acquired in its recent Flushing Financial acquisition, reducing exposure to rent-regulated properties. The company said the purchase price was consistent with valuation estimates disclosed when the acquisition was announced, and it will report further balance sheet details in its second quarter earnings release.
Sold more than 1,400 multifamily loans with an aggregate balance of $1.3 billion
Rent-regulated collateral accounted for $736 million of the sold portfolio
Exposure to loans with greater than 50% rent-regulated units now less than 2.5% of total assets
Loans were originated by Flushing Bank and acquired through the merger on June 1, 2026
Quantum Leap Acquisition Corp said the underwriters of its initial public offering fully exercised their over-allotment option, with the final 2,082,608 units closing on June 22, 2026. Total units sold rose to 23,000,000, for aggregate gross proceeds of $230 million at $10.00 per unit. The filing is an administrative update on the offering and does not change the company's business plan.
Underwriters gave notice on June 18, 2026 of their exercise of the remaining 2,082,608 over-allotment units; closing occurred June 22, 2026.
Total units sold reached 23,000,000, with aggregate gross proceeds of $230 million at $10.00 per unit.
Class A ordinary shares and warrants began separate trading on the NYSE on June 23, 2026, under the symbols QLEP and QLEP WS.
Globe Life signed a new $450 million term loan and a third amended credit agreement on June 26, 2026, with Wells Fargo replacing Bank of America as administrative agent. The filing shows the company extended its borrowing arrangements, with the term loan maturity moved to June 26, 2029 and the credit agreement maturity moved to June 26, 2031.
Term loan principal increased from $250 million to $450 million, with maturity extended from August 15, 2027 to June 26, 2029.
Credit agreement maturity extended from March 29, 2029 to June 26, 2031.
Wells Fargo, National Association replaces Bank of America, N.A. as administrative agent under both agreements.
The filing does not state the credit agreement's total commitment amount.
Four Corteva directors, Karen Grimes, Marcos Lutz, Charles Magro and Kerry Preete, agreed to resign from the Corteva board effective immediately before the planned spin-off of the seed business into Vylor, Inc. The filing says each is expected to join the Vylor board, and the resignations are not tied to any disagreement with the company. The companies also announced their post-separation boards, and the separation remains on track for the fourth quarter of 2026.
Resignations agreed June 26, 2026, and take effect only if the spin-off is completed
Greg Page to chair a nine-person Corteva board; Luke Kissam to join at separation
Karen Grimes to chair a seven-director Vylor board; a search is ongoing for at least one more member
Vylor filed its first Form 10 registration statement with the SEC; separation on track for 4Q 2026
Andersen Tax LLC, an indirect subsidiary of Andersen Group Inc., entered into a $50.0 million asset-based revolving credit agreement with JPMorgan Chase Bank, N.A. on June 25, 2026. The facility matures three years from closing, bears interest at Term SOFR plus 175 basis points, and is guaranteed by Andersen Group Inc. and other Loan Parties, secured by a first lien on their assets. The filing does not report any change in reported revenue or earnings, but it sets new borrowing capacity and restrictions on distributions and acquisitions for the group.
$50.0 million revolving credit facility dated June 25, 2026, maturing three years from the Closing Date
Interest at Term SOFR plus 175 basis points; unused line fee of 25 basis points per annum
Springing minimum fixed charge coverage ratio of 1.00x applies if availability falls below 25% of the line cap
Domestic acquisitions limited to $25 million in total consideration; foreign acquisitions capped at $15 million per transaction and $75 million per year
Protara Therapeutics said its Chief Medical Officer, Leonardo Viana Nicacio, M.D., resigned to explore other opportunities, effective June 26, 2026. His duties will be taken over by Carla Beckham, M.D., and will continue under the oversight of Jacqueline Zummo, Ph.D., the company's Chief Research & Development Officer.
Leonardo Viana Nicacio, M.D., Chief Medical Officer, resigned effective June 26, 2026, to explore other opportunities
Carla Beckham, M.D., Lead Medical Director and Head of Clinical Development, will assume Dr. Nicacio's duties
Jacqueline Zummo, Ph.D., Chief Research & Development Officer, will oversee the work
At its June 26, 2026 annual meeting, American Eagle Outfitters stockholders approved an amended and restated 2023 Stock Award and Incentive Plan. The amendment adds 9,680,000 shares, extends the plan's term from 2033 to 2036, and raises the non-employee director award limit from $750,000 to $1,000,000. The added share pool gives the company more room for equity awards, which affects how much stock is available to be granted.
The 2023 Plan adds 9,680,000 shares and its term is extended from 2033 to 2036.
The non-employee director award limit rises from $750,000 to $1,000,000.
Jay L. Schottenstein was elected Class I director with 121,484,517 votes for and 18,267,830 against.
The plan amendment passed with 134,900,287 votes for and 4,853,755 against; EY was ratified with 143,082,504 votes for.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.